Tag: bladder
Merck, plagued by limited supply of bladder cancer drug, will build...
During its years as sole producer of a difficult-to-make cancer med in high demand, Merck & Co.'s limited capacity has hamstrung its efforts to...
ESMO: Merck’s Keytruda-chemo combo shows survival ‘trend,’ but can’t top chemo...
Merck’s Keynote-361 study in newly diagnosed metastatic bladder cancer asked a key question: Could adding Keytruda to chemo improve on chemo, the standard of...
Merck’s Keytruda flops bladder cancer trial, giving Roche’s Tecentriq an open...
Merck & Co.’s Keytruda has several clinical wins under its belt that have led to a long list of FDA approvals. But it can’t...
